Bristol-Myers Squibb

We have a strong legacy in discovering and developing cancer medicines dating back 40 years and our researchers continuing pursuit of new strategies to answer the unmet needs of patients has resulted in the emergence of a robust pipeline of anti-cancer agents. Identification of specific targets has facilitated the creation of molecules designed for their potential to inhibit tumour growth, survival and metastasis. In the next few years, we hope that our decades of cancer research will result in the development of innovative medicines to fight aggressive and previously drug-resistant tumours.